Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
How should chronic pain in children be approached?
There is limited research on the effectiveness of pharmacotherapy in treating in children with chronic pain. So what is the best approach and how...
From the President: Pharmacists’ support valued during 2021
'I would like to take this opportunity to thank you for your valued support during 2021,' writes PSA National President A/Prof Chris Freeman.
Listings for biosimilar uptake drivers expanded
Amended prescribing information has been released for two biosimilar uptake drivers listed on the Pharmaceutical Benefits Scheme (PBS), as part of the Biosimilar Awareness...
Budget’s funding welcome, but more is needed for pharmacy
PSA has welcomed the government’s commitment to pharmacy in the 2019-20 Federal Budget through the extension of the Administration Handling and Infrastructure (AHI) fee...
Medicine safety: The big picture
Dr Libby Roughead MPS is Senior Principal Research Fellow at the University of South Australia’s School of Pharmacy, where her work focuses on quantifying...
Minor Ailments Scheme gets 10/10 from Scottish patients
A new report indicates the ‘undeniable popularity’ of Scotland’s Minor Ailment Scheme (MAS), as support swells amongst pharmacy groups for its implementation in Australia....
